Torrent Pharma to acquire Curatio Healthcare for Rs. 2,000 Cr

The consideration includes Rs. 115 crore (on the date of signing) of cash and cash equivalents in the acquired business indicating an Enterprise Value of Rs. 1,885 crore

Hester planning capacity expansion for Goat Pox vaccine

Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine and as soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine

CellOrigin Biotech collaborates with Qilu Pharma to develop CAR-iMAC Cell Therapy

NATCO launches Chlorantraniliprole (CTPR) formulated product NATGEN

NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.

Aptar Pharma collaborates with Fluidda

The companies will leverage their respective proprietary technology platforms

Snazzy launches scan box and remote monitoring app to achieve 100% orthodontic goals

The startup plans to provide free technology to dental clinics upon registration.

Lupin receives approval from US FDA for Diclofenac Sodium Topical Solution USP

Diclofenac Sodium Topical Solution USP, 2% w/w (RLD Pennsaid) had estimated annual sales of US $484 million in the US

Shilpa Medicare Hyderabad facility receives US FDA clearance

The facility is identified as a testing laboratory in numerous ANDAs filed by Shilpa Medicare Limited and its agreed parties

Lynparza approved in China as first-line maintenance treatment with Bevacizumab for HRD- positive advanced ovarian cancer

One in two women with advanced ovarian cancer has an HRD-positive tumor

JB Pharma witness 20% growth in August 2022: IQVIA

Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.